Search

ABSTRACT Background Methods Results Conclusions Odontogenic keratocyst (OKC) is a partial manifestation of Gorlin syndrome (GS), resulting from the abnormal activation of the hedgehog signaling pathway. OKC predominantly occurs in young adults and is mostly asymptomatic at the time of initial diagnosis. As OKC is asymptomatic, GS can be challenging to diagnose in certain instances. In this study, we attempted to identify asymptomatic GS from sporadic OKC cases using a previously developed gene panel for GS.Genomic DNA was extracted from patient samples. These DNA samples were analyzed using the AmpliSeq Custom DNA Panel (Illumina), which was specifically designed to target four previously established genes (PTCH1, PTCH2, SMO, and SUFU). Mutations from patients were predicted using tools, such as MutationTaster, CADD, and Polyphen‐2.Thirty‐one patients with OKC were included: 22 sporadic, 9 syndromic, 14 cases with dentigerous cysts, and 3 patients with orthokeratinized odontogenic cysts. One patient with sporadic OKC carried 50% genetic mutation in the cyst and blood, indicative of GS. PTCH1 mutations were found in one of the 14 patients with dentigerous cysts, 3 of the 17 first‐time sporadic cases, and all four recurrent cases. Resected OKC tissues revealed a PTCH1 mutation.We found one patient with GS from those diagnosed with sporadic OKC. Our findings suggest that PTCH1 mutations are associated with postoperative recurrence of OKC, implying that hedgehog‐related gene variations may contribute to jaw cyst development and improve the prognosis of OKC. [ABSTRACT FROM AUTHOR]

Simple Summary: Nutritional assessment indicators have been recognized as useful in predicting treatment-related adverse events. In maintenance therapy with PARP inhibitors in ovarian cancer, treatment discontinuation due to treatment-related adverse events has been reported, but factors predicting these events are not identified. Our study suggested that PNI and mGPS can predict the risk of treatment discontinuation due to PARP inhibitor-related adverse events before starting maintenance therapy. This insight opens avenues for more personalized treatment plans, potentially improving patient outcomes. Background: Nutritional status is an important factor influencing toxicity of treatment. Nutritional assessment indicators such as the Prognostic Nutritional Index (PNI), Controlling Nutritional Status (CONUT) score and modified Glasgow Prognostic Score (mGPS) have been reported to be associated with treatment-related adverse events (AEs) for various malignancies. However, there are no reports investigating the relationship between nutritional status and AEs from poly-(ADP-ribose) polymerase (PARP) inhibitors (PARPi), which are widely used in recent years as maintenance therapy for ovarian cancer. Objective: The primary objective was to investigate the usefulness of nutritional assessment indicators in predicting treatment discontinuation due to AEs from PARPi. Methods: This multicenter retrospective study included patients diagnosed with ovarian cancer who received maintenance therapy with PARPi from January 2018 to December 2023. PNI, CONUT score, and mGPS were calculated based on hematological parameters measured within 7 days before the start of PARPi therapy. Results: A total of 272 patients received maintenance therapy with PARPi during the period, but due to the absence of the blood collection of albumin levels within one week or other exclusion criteria, 71 patients were finally included in this analysis. AEs were seen in 59 patients (83.1%), including 25 (35.2%) severe events (grade ≥3 in Common Terminology Criteria for Adverse Events v5.0). Eighteen patients (25.4%) discontinued treatment due to PARPi-related AEs. Low PNI (<48.44) and high mGPS (≥1) were predictors of treatment discontinuation in both univariate and multivariate analyses. CONUT was not a significant predictor in this study. Conclusions: Our study suggested that PNI and mGPS can predict the risk of treatment discontinuation due to PARPi-related AEs before starting maintenance therapy. This insight opens avenues for more personalized treatment plans, potentially improving patient outcomes. [ABSTRACT FROM AUTHOR]

Discusses and compares results of a survey of teacher's perceptions of school libraries in Tokyo, Japan and in Honolulu, Hawaii that showed differences in policies, availability of trained school library personnel, and in the nature of school library development. Copies of the questionnaires used are appended. (Author/LRW)

A synthetic method for planar catechin analogues (PCn) is examined, the lipophilicity of which was controlled by changing the length of the alkyl chains and their remarkable antioxidative potencies and [alpha]-glucosidase inhibitory activities. These planar catechin analogues might be used as a lead compounds for the development of antidiabetic therapeutics, similar to acarbose and voglibose which are known to reduce postprandial hyperglycemia primarily by interfering with the carbohydrate digesting enzymes and delaying glucose absorption.